Research map: Treatment Strategies in Incident and Recurrent Hyperkalemia: Insights from the TRACK Study

Back to the article

Papers in this map

  1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease · Paul E. Stevens · 2024 · 8239 citations · Cited by this paper
  2. Hyperkalemia Management in the US Cohort of the Prospective, Observational, Real-World TRACK Study · Elvira O. Gosmanova · 2026 · Cites this paper
  3. Factors Associated with Favorable One-Year Outcomes After PreserFlo MicroShunt Implantation: Insights from Anterior Segment Optical Coherence Tomography · 2026 · Related
  4. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · Paul A. Heidenreich · 2022 · 2283 citations · Cited by this paper
  5. Uncontrolled Hypertension Prevalence, Characteristic Profiles, and Risk of Cardiorenal and Metabolic Outcomes: Insights from the EnligHTN Study · 2026 · Related
  6. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease · Alfred K. Cheung · 2021 · 1444 citations · Cited by this paper
  7. Diagnostic Delay in Multiple Sclerosis in China: A Nationwide Cross-Sectional Study · 2026 · Related
  8. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference · Catherine M. Clase · 2019 · 504 citations · Cited by this paper
  9. Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors Study · 2026 · Related
  10. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials · Xinfang Xie · 2015 · 495 citations · Cited by this paper
  11. Assessment of the MFSAF v4.0 and PROMIS Fatigue 7a to Measure Outcomes in Myelofibrosis: Validation from a Non-interventional Mixed Methods Study · 2026 · Related
  12. 2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure · Authors/Task Force Members: · 2024 · 464 citations · Cited by this paper
  13. Long-Term Effects of Exercise During Pregnancy on the Metabolic Health of Mothers with Overweight/Obesity and Their Offspring: An 8- to 10-Year Follow-Up Study · 2026 · Related
  14. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis · Csaba Pal Kovesdy · 2018 · 349 citations · Cited by this paper
  15. Expert Consensus on the Clinical Application of Sulodexide in Vascular Diseases · 2026 · Related
  16. Clinical Management of Hyperkalemia · Biff F. Palmer · 2020 · 183 citations · Cited by this paper
  17. An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics · 2026 · Related
  18. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection · Christian M. Werner · 2008 · 167 citations · Cited by this paper
  19. Budget Impact of Eplerenone for Heart Failure with Reduced Ejection Fraction: National Perspective and Regional Implications in Italy · 2026 · Related
  20. Potassium Binders for Hyperkalemia in Chronic Kidney Disease—Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis · Biff F. Palmer · 2019 · 113 citations · Cited by this paper
  21. Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan · Naoki Kashihara · 2019 · 92 citations · Cited by this paper
  22. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers · Marsha A. Raebel · 2006 · 89 citations · Cited by this paper
  23. How common is hyperkalaemia? A systematic review and meta-analysis of the prevalence and incidence of hyperkalaemia reported in observational studies · Toby J L Humphrey · 2021 · 84 citations · Cited by this paper
  24. Impact of Dietary Potassium Restrictions in CKD on Clinical Outcomes: Benefits of a Plant-Based Diet · Deborah Joy Clegg · 2020 · 75 citations · Cited by this paper
  25. Current Management of Hyperkalemia in Patients on Dialysis · Shweta Bansal · 2020 · 62 citations · Cited by this paper
  26. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia · Eiichiro Kanda · 2023 · 59 citations · Cited by this paper
  27. Prevalence and economic burden of hyperkalemia in the United States Medicare population · Fan Mu · 2020 · 52 citations · Cited by this paper
  28. Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia · Bertram Pitt · 2016 · 33 citations · Cited by this paper
  29. Real-world management of hyperkalemia with patiromer among United States Veterans · Csaba Pal Kovesdy · 2020 · 28 citations · Cited by this paper
  30. Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors · Luca De Nicola · 2023 · 28 citations · Cited by this paper
  31. Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization · Nihar R. Desai · 2020 · 23 citations · Cited by this paper
  32. Maintained renin–angiotensin–aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study · Anjay Rastogi · 2024 · 23 citations · Cited by this paper
  33. Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review · Christoph Wanner · 2025 · 13 citations · Cited by this paper
  34. Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists · Anjay Rastogi · 2024 · 12 citations · Cited by this paper
  35. Inpatient management and post-discharge outcomes of hyperkalemia · Jill R. Davis · 2021 · 8 citations · Cited by this paper
  36. Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study · Abiy Agiro · 2025 · 6 citations · Cited by this paper
  37. Interdisciplinary recommendations for recurrent hyperkalaemia: insights from the GUARDIAN-HK European Steering Committee · Gianluigi Savarese · 2025 · 4 citations · Cited by this paper
  38. Design and cohort characteristics of TRACK, a prospective study of hyperkalaemia management decision-making · Judith A. Hsia · 2024 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)